ARCHIVES

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

This article is from The Cancer Letter archive.

Vol. 22 No. 31 | August 2, 1996

Download PDF Visit The Full Archive

Related Articles

SWOG Restarts Gynecologic Malignancies Committee.

May 16, 2008

FDA Official Outlines agency’s Views On Efficacy Requirement

June 16, 1999

In Brief: Rhoads Renamed Cancer Advisory Board Chairman; L-B’s Frederick Contract Renewed For $12 Million

June 28, 1974

OMB Restrictions On Reprogramming Could Result In Inefficient Last Minute Spending By Institutes

September 13, 1985

In Brief: New Greg For Surgery Research Approved; Only 30 Bioassay Program Reports Still In Backlog

April 21, 1978

Advocates Call For Metrics And Action Plan In NCI’s Redesign of Cooperative Groups

July 8, 2011